FDA Grants Emergency Authorization For Blood Plasma To Treat Covid-19

The U.S. Food and Drug Administration issued an emergency use authorization or EUA for investigational convalescent plasma to treat COVID-19 in hospitalized patients. The blood from those people who have recovered from the disease is called convalescent plasma. According to the health regulator, the potential promising treatment has been received by more than 70,000 patients in the country.